Search
Capricor Therapeutics Inc
CAPRAdd to Watchlist
8.570USD
-0.100-1.15%
Close 09-24 16:00（ET）
496.29MMarket Cap
LossP/E TTM
After-hours 16:57 (ET)8.570USD+0.015+0.17%
After-hours 16:57 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.15%
5 Days
-9.02%
1 Month
+26.03%
6 Months
-70.32%
Year to Date
-70.30%
1 Year
+38.45%
Key Figures
8.600Open
9.360High
192.61KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.33%Turnover Ratio
8.670Prev. Close
8.290Low
1.65MTurnover
LossP/E Static
2.02P/B
0.00%Div Yield TTM
-47.74%ROA
40.37052wk High
24.61Volume Ratio
-40.47MNet Profit
57.91MShares
-2.3165EPS TTM
0.40Beta
-56.40%ROE
2.96052wk Low
12.34%Amplitude
100.00%Gross Margin
496.29MMarket Cap
-12.17Reward/Risk
24.84%Risk Rate
Capricor Therapeutics Inc's Score
0.00vs previous score
Forecast7.80
Financial Health5.67
Technical4.72
Valuation Dimensions6.43
Institutional Confidence5.00
Risk Assessment1.83
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Capricor Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Capricor Therapeutics Inc Latest Earnings Call Transcripts
Capricor Therapeutics (CAPR) Q2 2026 Earnings Call: Deramocel BLA Path and FDA Update
Capricor Therapeutics’ Q2 2026 earnings call covered its deramocel BLA amendment plan, $237.9 million cash balance and $40.7 million net loss.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.70/-0.59
Revenue / Forecast
0.00/0.00
Capricor Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCAPR
Number of employees160
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Nippon Shinyaku Co Ltd | 8.55% |
| Suvretta Capital Management, LLC | 5.91% |
| Tang Capital Management, LLC | 5.88% |
| BlackRock Institutional Trust Company, N.A. | 4.51% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 25.82% |
| Investment Advisor | 15.86% |
| Corporation | 8.55% |
| Investment Advisor/Hedge Fund | 8.33% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of Capricor Therapeutics Inc (CAPR)?
The current price of Capricor Therapeutics Inc (CAPR) is 8.57.
What is the symbol of Capricor Therapeutics Inc?
The ticker symbol of Capricor Therapeutics Inc is CAPR.
What is the 52-week high of Capricor Therapeutics Inc?
The 52-week high of Capricor Therapeutics Inc is 40.37.
What is the 52-week low of Capricor Therapeutics Inc?
The 52-week low of Capricor Therapeutics Inc is 2.96.
What is the market capitalization of Capricor Therapeutics Inc?
The market capitalization of Capricor Therapeutics Inc is 496.29M.
Is Capricor Therapeutics Inc (CAPR) currently rated as Buy, Hold, or Sell?
According to analysts, Capricor Therapeutics Inc (CAPR) has an overall rating of Buy, with a price target of 23.67.
What is the Earnings Per Share (EPS TTM) of Capricor Therapeutics Inc (CAPR)?
The Earnings Per Share (EPS TTM) of Capricor Therapeutics Inc (CAPR) is -2.32.